1Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China
2GE Healthcare (China), Beijing, China
Presenting Author: Shuo Wang
Synopsis
Motivation:
Goals:
Approach:
Results:
Preview figure
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public on 13 May 2028.
To request or purchase access, contact the ISMRM Central Office at support@ismrm.org.
1. Sun S, Zhou J, Bai Y, et al. Role of oedema and shrinkage patterns for prediction of response to neoadjuvant chemotherapy and survival outcomes in luminal breast cancer. Clin Radiol. 2024;79(8):e1010-e1020. Doi:10.1016/j.crad.2024.04.021 [doi]
2. Huang Y, Song X, Chen Y, et al. Intratumoral Microbiome-related MRI Model for Predicting Breast Cancer Shrinkage Pattern Following Neoadjuvant Therapy. Radiology. 2025;316(2):e243545. Doi:10.1148/radiol.243545 [doi]
3. Chen X, Luo Y, Xie Z, Wen Y, Mou F, Zeng W. Prediction of neoadjuvant chemotherapy efficacy in breast cancer: integrating multimodal imaging and clinical features. BMC Med Imaging. 2025;25(1):118. Published 2025 Apr 14. Doi:10.1186/s12880-025-01631-2 [doi]
4. Gong X, Wang X, Wang L, et al. Comparing Multi-b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology. 2025;316(1):e242969. Doi:10.1148/radiol.242969 [doi]
5. Huang YH, Shi ZY, Zhu T, et al. Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer. Adv Sci (Weinh). 2025;12(12):e2413702. Doi:10.1002/advs.202413702 [doi]
6. Liu C, Huang X, Chen X, et al. Use of Pretreatment Multiparametric MRI to Predict Tumor Regression Pattern to Neoadjuvant Chemotherapy in Breast Cancer. Acad Radiol. 2023;30 Suppl 2:S62-S70. Doi:10.1016/j.acra.2023.02.024 [doi]